LPL Financial’s Definium Therapeutics DFTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.48M Buy
78,271
+1,035
+1% +$17.6K ﹤0.01% 3799
2025
Q4
$1.03M Buy
77,236
+1,289
+2% +$16K ﹤0.01% 4043
2025
Q3
$895K Buy
75,947
+7,458
+11% +$69.6K ﹤0.01% 4104
2025
Q2
$444K Buy
68,489
+1,056
+2% +$6.95K ﹤0.01% 4469
2025
Q1
$394K Buy
67,433
+5,099
+8% +$36.5K ﹤0.01% 4374
2024
Q4
$434K Buy
62,334
+14,439
+30% +$99.3K ﹤0.01% 4216
2024
Q3
$273K Buy
47,895
+1,630
+4% +$11.3K ﹤0.01% 4510
2024
Q2
$334K Buy
46,265
+2,538
+6% +$22.2K ﹤0.01% 4185
2024
Q1
$411K Buy
43,727
+8,497
+24% +$48.5K ﹤0.01% 3936
2023
Q4
$129K Buy
35,230
+14,079
+67% +$42.4K ﹤0.01% 4505
2023
Q3
$66.2K Buy
21,151
+316
+2% +$1.3K ﹤0.01% 4482
2023
Q2
$74.4K Buy
20,835
+3
+0% +$10 ﹤0.01% 4379
2023
Q1
$66K Buy
20,832
+2,277
+12% +$7.57K ﹤0.01% 4272
2022
Q4
$40.8K Buy
18,555
+668
+4% +$1.85K ﹤0.01% 4294
2022
Q3
$63K Sell
17,887
-33,760
-65% -$324K ﹤0.01% 4200
2022
Q2
$496K Buy
+51,647
New +$653K ﹤0.01% 3207
2022
Q1
Sell
-25,814
Closed -$534K 4322
2021
Q4
$534K Buy
25,814
+22,888
+782% +$731K ﹤0.01% 3221
2021
Q3
$102K Sell
2,926
-19
-0.6% -$821 ﹤0.01% 4139
2021
Q2
$152K Buy
+2,945
New +$155K ﹤0.01% 3974

Other funds holding DFTX

LPL Financial's DFTX Position: Q1 2026 in Review

LPL Financial increased its Definium Therapeutics (DFTX) stake by 1.3% in Q1 2026, buying an estimated $17.6K and bringing the position to 78,271 shares worth $1.48M. The position accounts for ﹤0.01% of the portfolio, ranked #3799.

LPL Financial first reported a position in DFTX in Q2 2021 and has held it in 19 quarters since. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.

  • LPL Financial held 78,271 shares of Definium Therapeutics worth $1.48M as of Q1 2026.
  • LPL Financial bought 1,035 Definium Therapeutics shares in Q1 2026, an estimated $17.6K.
  • Definium Therapeutics made up ﹤0.01% of LPL Financial's portfolio in Q1 2026, its #3799 holding.
  • LPL Financial first reported a position in Definium Therapeutics in Q2 2021 and has held it in 19 quarters since.
  • 247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.

Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.